Insider Shareholders with Direct Ownership of Lian Bio (LIAN)
This section provides a comprehensive overview of the insiders with direct ownership of Lian Bio (LIAN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LianBio Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Debra Yu
Officer |
1,000,000 | 0 | 1,000,000 $300,000 | 1 |
May 04, 2022
Added 50.0%
|
Yizhe Wang
Chief Executive Officer |
907,498 | 0 | 907,498 $272,249 | 1 |
Mar 29, 2023
Added 50.0%
|
Yi Larson
Chief Financial Officer |
325,901 | 0 | 325,901 $97,770 | 1 |
Mar 29, 2023
Added 50.0%
|
Jiang Qian
SVP, China General Manager |
293,593 | 2,239 | 291,354 $87,406 | 3 |
Mar 29, 2023
Added 43.47%
|
Brianne Jahn
Chief Business Officer |
224,005 | 0 | 224,005 $67,201 | 1 |
Mar 29, 2023
Added 50.0%
|
Anastasios Gianakakos
Director |
72,848 | 19,218 | 53,630 $16,089 | 3 |
Feb 15, 2024
Reduced 26.38%
|
Susan Michele Silbermann
Director |
36,300 | 19,218 | 17,082 $5,124 | 2 |
Feb 15, 2024
Reduced 52.94%
|
Konstantin Poukalov
Director |
36,300 | 19,218 | 17,082 $5,124 | 2 |
Feb 15, 2024
Reduced 52.94%
|
Adam Leo Stone
Interim CEO |
36,300 | 19,218 | 17,082 $5,124 | 2 |
Feb 15, 2024
Reduced 52.94%
|
Ehong Gu
Interim CFO |
0 | 19,620 | 0 $0 | 2 |
Apr 09, 2024
Reduced 100.0%
|